16th Edition R&D Controlling and Performance Management

March 16 – 18, 2026 | Amsterdam, Netherlands

Transform uncertainty into value - make R&D controlling a driver of innovation and strategy.

 
Innovation and R&D as disciplines are currently undergoing a host of changes, and they must reinvent the way they’re working. Large R&D state of the art organizations are being disrupted on several levels: There are less funds available; disruptive, cheaper technology is out there, sometimes open-source, and that affects the way R&D is working; end-consumers want more say and customization in the products they are expecting. Thus, expectations from R&D are changing. For one, there is more pressure to respond to market trends and customer needs and come up with products that are commercially successful.  
 
The Marcus Evans 16th Edition R&D Controlling and Performance Management conference taking place in Amsterdam, Netherlands on 16-18 March, 2026 will tackle into some of the toughest challenges R&D controllers face today: securing funding for projects with uncertain outcomes, making the intangible value of innovation visible, and balancing transparency with the freedom researchers need to create. This conference will guide you through practical tools and real scenarios to transform uncertainty into actionable choices. You’ll learn how to build flexible budgets that withstand change, translate innovation into business value executives can back, and confidently sell R&D as a strategic growth driver.

This edition also equips you to design KPIs that drive impact instead of bureaucracy, manage portfolios with discipline, and make tough stop/pivot decisions without regret. Just as importantly, you’ll develop the influence skills to earn trust with researchers, connect across silos, and turn data into compelling stories leaders act on. You’ll walk away with frameworks, hands-on methods, and communication techniques that elevate R&D controlling from a reporting function into a true strategic partner for innovation and competitiveness.
 
Topics Covered:
* Winning the Case for Innovation – How to Sell R&D Value and Secure Funding
* Turning Strategy into a Compass for R&D Investment Decisions
* Shaping Mindsets and Communication to Amplify R&D Controlling’s Impact
* Capturing Innovation Value Beyond Traditional ROI
* Designing KPIs That Actually Drive R&D Impact
* Future-Proofing R&D Controlling with Advanced Technologies & ESG Tools

Best Practices and Case Studies from:
* James Lane, Global Process & Performance Manager, Imperial Brands, UK
* Loïk-Maël Nys, Head of Finance for IBA Clinical, IBA, Belgium
* Marco Secreto, Head of R&D Portfolio & Project Management Governance, Iveco Group, Italy
* Ugur Savan, R&D Controller, MENARINI Group, USA
* Eyal Dayan, Head of Commercial Finance, Polpharma Group, Netherlands
* Arnaud Ducarouge, R&D Finance Global Process Lead, Sanofi, France
 
Special discounts available to Bio-Equip members! For more information please contact: Stefanos Ioannou, Digital Media and PR Executive at stefanosi@marcusevanscy.com  or visit: https://tinyurl.com/rzwnhzjt